Vibha Anand
Overview
Explore the profile of Vibha Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
603
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Investigating the impact of steroid dependence on gastrointestinal surgical outcomes from UK Biobank
Kartoun U, Koseki A, Kosugi A, Njoku K, Yadete T, Koski E, et al.
Sci Rep
. 2024 Nov;
14(1):29243.
PMID: 39587092
Although corticosteroids are an important treatment for inflammatory bowel disease (IBD) patients, many subjects develop dependence, leading to serious long-term side effects. We applied causal inference analyses to investigate the...
2.
Ghalwash M, Anand V, Ng K, Dunne J, Lou O, Lundgren M, et al.
Diabetes Care
. 2024 Jun;
47(8):1424-1431.
PMID: 38861550
Objective: To characterize distinct islet autoantibody profiles preceding stage 3 type 1 diabetes. Research Design And Methods: The T1DI (Type 1 Diabetes Intelligence) study combined data from 1,845 genetically susceptible...
3.
Purpura A, Mulligan N, Kartoun U, Koski E, Anand V, Bettencourt-Silva J
AMIA Jt Summits Transl Sci Proc
. 2024 Jun;
2024:384-390.
PMID: 38827064
This paper addresses the challenge of binary relation classification in biomedical Natural Language Processing (NLP), focusing on diverse domains including gene-disease associations, compound protein interactions, and social determinants of health...
4.
Neehal N, Anand V, Bennett K
AMIA Annu Symp Proc
. 2024 Jan;
2023:530-539.
PMID: 38222411
Randomized Clinical Trials (RCTs) measure an intervention's efficacy, but they may not be generalizable to a desired target population if the RCT is not equitable. Thus, representativeness of RCTs has...
5.
Kartoun U, Njoku K, Yadete T, Ravid S, Koski E, Ogallo W, et al.
AMIA Annu Symp Proc
. 2024 Jan;
2023:426-435.
PMID: 38222374
Chronic gastrointestinal (GI) conditions, such as inflammatory bowel diseases (IBD), offer a promising opportunity to create classification systems that can enhance the accuracy of predicting the most effective therapies and...
6.
Kartoun U, Fahed A, Kany S, Singh P, Khurshid S, Patel A, et al.
Eur Heart J Open
. 2023 Jun;
3(3):oead059.
PMID: 37377635
No abstract available.
7.
Frohnert B, Ghalwash M, Li Y, Ng K, Dunne J, Lundgren M, et al.
Diabetes Care
. 2023 Mar;
46(10):1753-1761.
PMID: 36862942
Objective: To estimate the risk of progression to stage 3 type 1 diabetes based on varying definitions of multiple islet autoantibody positivity (mIA). Research Design And Methods: Type 1 Diabetes...
8.
Ghalwash M, Anand V, Lou O, Martin F, Rewers M, Ziegler A, et al.
Lancet Child Adolesc Health
. 2023 Jan;
7(4):261-268.
PMID: 36681087
Background: Screening for islet autoantibodies in children and adolescents identifies individuals who will later develop type 1 diabetes, allowing patient and family education to prevent diabetic ketoacidosis at onset and...
9.
Ng K, Anand V, Stavropoulos H, Veijola R, Toppari J, Maziarz M, et al.
Diabetologia
. 2022 Oct;
66(1):93-104.
PMID: 36195673
Aims/hypothesis: The aim of this study was to explore the utility of islet autoantibody (IAb) levels for the prediction of type 1 diabetes in autoantibody-positive children. Methods: Prospective cohort studies...
10.
Kwon B, Achenbach P, Anand V, Frohnert B, Hagopian W, Hu J, et al.
Diabetes
. 2022 Sep;
71(12):2632-2641.
PMID: 36112006
In our previous data-driven analysis of evolving patterns of islet autoantibodies (IAb) against insulin (IAA), GAD (GADA), and islet antigen 2 (IA-2A), we discovered three trajectories, characterized according to multiple...